HADLIMA PUSHTOUCH 40 MG/0.8 ML

adalimumab-bwwd
$632.2410per ML

Strength

40 mg/.8mL

Manufacturer

Organon LLC

NDC

78206018401

Classification

Brand Biologic

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Last Updated

2/18/2026

Active Ingredients

ADALIMUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761059

On Market Since

7/1/2023

Pharmacological Classes

Antibodies
Monoclonal
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.3%

3Y

N/A

5Y

N/A

All

+0.3%